162 related articles for article (PubMed ID: 29417935)
21. Effects of hydroxysafflor yellow A on proliferation and collagen synthesis of rat vascular adventitial fibroblasts induced by angiotensin II.
Yuan W; Yang D; Sun X; Liu W; Wang L; Li X; Man X; Fu Q
Int J Clin Exp Pathol; 2014; 7(9):5772-81. PubMed ID: 25337218
[TBL] [Abstract][Full Text] [Related]
22. Hydroxysafflor yellow A promotes neovascularization and cardiac function recovery through HO-1/VEGF-A/SDF-1α cascade.
Wei G; Yin Y; Duan J; Guo C; Zhu Y; Wang Y; Xi M; Wen A
Biomed Pharmacother; 2017 Apr; 88():409-420. PubMed ID: 28122306
[TBL] [Abstract][Full Text] [Related]
23. Nucleolin mediated pro-angiogenic role of Hydroxysafflor Yellow A in ischaemic cardiac dysfunction: Post-transcriptional regulation of VEGF-A and MMP-9.
Zou J; Wang N; Liu M; Bai Y; Wang H; Liu K; Zhang H; Xiao X; Wang K
J Cell Mol Med; 2018 May; 22(5):2692-2705. PubMed ID: 29512890
[TBL] [Abstract][Full Text] [Related]
24. Effect of Hydroxysafflor yellow A on human umbilical vein endothelial cells under hypoxia.
Ji DB; Zhang LY; Li CL; Ye J; Zhu HB
Vascul Pharmacol; 2009; 50(3-4):137-45. PubMed ID: 19084079
[TBL] [Abstract][Full Text] [Related]
25. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
Pan R; Zhang Y; Zang B; Tan L; Jin M
J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
[TBL] [Abstract][Full Text] [Related]
26. Hydroxysafflor Yellow A Ameliorates Myocardial Ischemia/Reperfusion Injury by Suppressing Calcium Overload and Apoptosis.
Ye J; Wang R; Wang M; Fu J; Zhang Q; Sun G; Sun X
Oxid Med Cell Longev; 2021; 2021():6643615. PubMed ID: 34093960
[TBL] [Abstract][Full Text] [Related]
27. Synergistic cardioprotective effects of Danshensu and hydroxysafflor yellow A against myocardial ischemia-reperfusion injury are mediated through the Akt/Nrf2/HO-1 pathway.
Hu T; Wei G; Xi M; Yan J; Wu X; Wang Y; Zhu Y; Wang C; Wen A
Int J Mol Med; 2016 Jul; 38(1):83-94. PubMed ID: 27176815
[TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma.
Ma XM; Yu H; Huai N
World J Gastroenterol; 2009 Aug; 15(31):3874-83. PubMed ID: 19701967
[TBL] [Abstract][Full Text] [Related]
29. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.
Jin M; Wang L; Wu Y; Zang BX; Tan L
Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256
[TBL] [Abstract][Full Text] [Related]
30. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma.
Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH
Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131
[TBL] [Abstract][Full Text] [Related]
31. HSYA alleviates secondary neuronal death through attenuating oxidative stress, inflammatory response, and neural apoptosis in SD rat spinal cord compression injury.
Pei JP; Fan LH; Nan K; Li J; Dang XQ; Wang KZ
J Neuroinflammation; 2017 May; 14(1):97. PubMed ID: 28468657
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanism of inhibition of the abnormal proliferation of human umbilical vein endothelial cells by hydroxysafflor-yellow A.
Wang J; Wang J; Wang X; Liu L; Hu J; Yu X; Xu Y; Niu X; Lin Z; Zhang Y; Zhang X; Zhang Q
Pharm Biol; 2016 Sep; 54(9):1800-7. PubMed ID: 26730646
[TBL] [Abstract][Full Text] [Related]
33. Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib.
Ramer R; Walther U; Borchert P; Laufer S; Linnebacher M; Hinz B
J Lipid Res; 2013 Nov; 54(11):3116-29. PubMed ID: 23943857
[TBL] [Abstract][Full Text] [Related]
34. The G1 phase arrest and apoptosis by intrinsic pathway induced by valproic acid inhibit proliferation of BGC-823 gastric carcinoma cells.
Zhao X; Yang W; Shi C; Ma W; Liu J; Wang Y; Jiang G
Tumour Biol; 2011 Apr; 32(2):335-46. PubMed ID: 21113745
[TBL] [Abstract][Full Text] [Related]
35. [Study on functions and mechanism of curcumin in inducing gastric carcinoma BGC apoptosis].
Qin HB; Wei L; Zhang JW; Tang JM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Nov; 27(11):1227-30. PubMed ID: 22078453
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory Effect of Hydroxysafflor Yellow B on the Proliferation of Human Breast Cancer MCF-7 Cells.
Qu C; Zhu W; Dong K; Pan Z; Chen Y; Chen X; Liu X; Xu W; Lin H; Zheng Q; Li D
Recent Pat Anticancer Drug Discov; 2019; 14(2):187-197. PubMed ID: 31096897
[TBL] [Abstract][Full Text] [Related]
37. Hydroxysafflor yellow A protects methylglyoxal-induced injury in the cultured human brain microvascular endothelial cells.
Li W; Liu J; He P; Ni Z; Hu Y; Xu H; Dai H
Neurosci Lett; 2013 Aug; 549():146-50. PubMed ID: 23774474
[TBL] [Abstract][Full Text] [Related]
38. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells.
Cheng Y; Ping J; Xu LM
Chin Med J (Engl); 2007 May; 120(9):794-801. PubMed ID: 17531121
[TBL] [Abstract][Full Text] [Related]
39. Hydroxysafflor yellow A protects PC12 cells against the apoptosis induced by oxygen and glucose deprivation.
Fan L; Dang X; Shi Z; Zhang C; Wang K
Cell Mol Neurobiol; 2011 Nov; 31(8):1187-94. PubMed ID: 21688125
[TBL] [Abstract][Full Text] [Related]
40. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A
PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
